Israel’s OncoHost (reported here previously) has achieved about 90% accuracy in predicting how melanoma and lung cancer patients respond to various therapies. And now Israeli Nobel Prize winner Professor Aaron Ciechanover has joined OncoHost’s scientific advisory board.

https://www.prnewswire.com/il/news-releases/oncohost-welcomes-nobel-prize-winner-to-scientific-advisory-board-301205142.html

https://jitc.bmj.com/content/8/Suppl_3/A11.2

https://www.timesofisrael.com/spotlight/nobel-prizewinner-ciechanover-hails-much-more-precise-cancer-treatment/

https://www.youtube.com/watch?v=j3IJFoPW60E